Persistent COVID: a challenge for today’s medicine

Authors

  • Hermys Vega Treto
  • Lázaro Aldama Pérez
  • Susana María Muñiz Espinosa
  • Karla Pérez Linares

Abstract

The pandemic due to the new coronavirus has caused a new nosological entity in patients recovered from this disease: Persistent COVID. There is collected evidence, as well as sufficient clinical experience to speak of a multiorgan symptomatic complex that affects those patients who have suffered covid-19 (with or without a confirmed diagnosis) and who remain with symptoms after its acute phase. A bibliographic review was carried out, in order to describe the clinical features that characterize persistent covid, and the working algorithm in these cases. Twenty-five scientific articles were referenced. It is concluded that after recovering from covid acute phase, a heterogeneous percentage of patients have remained with symptoms of the illness for weeks and, even months, which include: dyspnea, cough, chest pain, headache, dizziness, anxiety, fatigue and taste and smell disorders.

Published

2021-10-30

How to Cite

1.
Vega Treto H, Aldama Pérez L, Muñiz Espinosa SM, Pérez Linares K. Persistent COVID: a challenge for today’s medicine. Invest Medicoquir [Internet]. 2021 Oct. 30 [cited 2025 Feb. 23];14(1). Available from: https://revcimeq.sld.cu/index.php/imq/article/view/752

Issue

Section

Artículos de revisión

Most read articles by the same author(s)

1 2 > >>